BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 27340107)

  • 21. Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients.
    Wikman H; Westphal L; Schmid F; Pollari S; Kropidlowski J; Sielaff-Frimpong B; Glatzel M; Matschke J; Westphal M; Iljin K; Huhtala H; Terracciano L; Kallioniemi A; Sauter G; Müller V; Witzel I; Lamszus K; Kemming D; Pantel K
    Oncotarget; 2014 May; 5(10):3076-87. PubMed ID: 24833255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequent genetic alterations in EGFR- and HER2-driven pathways in breast cancer brain metastases.
    Hohensee I; Lamszus K; Riethdorf S; Meyer-Staeckling S; Glatzel M; Matschke J; Witzel I; Westphal M; Brandt B; Müller V; Pantel K; Wikman H
    Am J Pathol; 2013 Jul; 183(1):83-95. PubMed ID: 23665199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene modules associated with breast cancer distant metastasis-free survival in the PAM50 molecular subtypes.
    Liu R; Zhang W; Liu ZQ; Zhou HH
    Oncotarget; 2016 Apr; 7(16):21686-98. PubMed ID: 26934123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes.
    Győrffy B; Bottai G; Fleischer T; Munkácsy G; Budczies J; Paladini L; Børresen-Dale AL; Kristensen VN; Santarpia L
    Int J Cancer; 2016 Jan; 138(1):87-97. PubMed ID: 26174627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer.
    Han J; Choi YL; Kim H; Choi JY; Lee SK; Lee JE; Choi JS; Park S; Choi JS; Kim YD; Nam SJ; Nam BH; Kwon MJ; Shin YK
    Breast Cancer Res Treat; 2017 Jul; 164(1):41-56. PubMed ID: 28409241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and verification of the PAM50-based Prosigna breast cancer gene signature assay.
    Wallden B; Storhoff J; Nielsen T; Dowidar N; Schaper C; Ferree S; Liu S; Leung S; Geiss G; Snider J; Vickery T; Davies SR; Mardis ER; Gnant M; Sestak I; Ellis MJ; Perou CM; Bernard PS; Parker JS
    BMC Med Genomics; 2015 Aug; 8():54. PubMed ID: 26297356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression profiles of breast cancer metastasis according to organ site.
    Brasó-Maristany F; Paré L; Chic N; Martínez-Sáez O; Pascual T; Mallafré-Larrosa M; Schettini F; González-Farré B; Sanfeliu E; Martínez D; Galván P; Barnadas E; Salinas B; Tolosa P; Ciruelos E; Carcelero E; Guillén C; Adamo B; Moreno R; Vidal M; Muñoz M; Prat A
    Mol Oncol; 2022 Jan; 16(1):69-87. PubMed ID: 34051058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
    Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J
    Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor.
    Sheffield BS; Kos Z; Asleh-Aburaya K; Wang XQ; Leung S; Gao D; Won J; Chow C; Rachamadugu R; Stijleman I; Wolber R; Gilks CB; Myles N; Thomson T; Hayes MM; Bernard PS; Nielsen TO; Chia SK
    Breast Cancer Res Treat; 2016 Feb; 155(3):483-90. PubMed ID: 26846986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene Expression Meta-Analysis of Potential Metastatic Breast Cancer Markers.
    Bell R; Barraclough R; Vasieva O
    Curr Mol Med; 2017; 17(3):200-210. PubMed ID: 28782484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast carcinoma with brain metastases: clinical analysis and immunoprofile on tissue microarrays.
    Brogi E; Murphy CG; Johnson ML; Conlin AK; Hsu M; Patil S; Akram M; Nehhozina T; Jhaveri KL; Hudis CA; Seidman AD
    Ann Oncol; 2011 Dec; 22(12):2597-2603. PubMed ID: 21427063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain metastasis in breast cancer: focus on genes and signaling pathways involved, blood-brain barrier and treatment strategies.
    Chhichholiya Y; Ruthuparna M; Velagaleti H; Munshi A
    Clin Transl Oncol; 2023 May; 25(5):1218-1241. PubMed ID: 36897508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors and survival of patients with brain metastasis from breast cancer who underwent craniotomy.
    Leone JP; Lee AV; Brufsky AM
    Cancer Med; 2015 Jul; 4(7):989-94. PubMed ID: 25756607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis.
    Klemm F; Bleckmann A; Siam L; Chuang HN; Rietkötter E; Behme D; Schulz M; Schaffrinski M; Schindler S; Trümper L; Kramer F; Beissbarth T; Stadelmann C; Binder C; Pukrop T
    Carcinogenesis; 2011 Mar; 32(3):434-42. PubMed ID: 21173432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of novel biomarkers associated with poor patient outcomes in invasive breast carcinoma.
    Canevari RA; Marchi FA; Domingues MA; de Andrade VP; Caldeira JR; Verjovski-Almeida S; Rogatto SR; Reis EM
    Tumour Biol; 2016 Oct; 37(10):13855-13870. PubMed ID: 27485113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanisms associated with breast cancer based on integrated gene expression profiling by bioinformatics analysis.
    Wu D; Han B; Guo L; Fan Z
    J Obstet Gynaecol; 2016 Jul; 36(5):615-21. PubMed ID: 26804550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraocular Metastases Secondary to Breast Carcinoma Correlates With Upregulation of Estrogen and Progesterone Receptor Expression in the Primary Tumor.
    Parrozzani R; Frizziero L; Testi I; Miglionico G; Perrini P; Pulze S; Pilotto E; Midena E
    Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):3944-8. PubMed ID: 27479811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SOX2 Promotes Brain Metastasis of Breast Cancer by Upregulating the Expression of FSCN1 and HBEGF.
    Xiao W; Zheng S; Xie X; Li X; Zhang L; Yang A; Wang J; Tang H; Xie X
    Mol Ther Oncolytics; 2020 Jun; 17():118-129. PubMed ID: 32322668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insights into the Steps of Breast Cancer-Brain Metastases Development: Tumor Cell Interactions with the Blood-Brain Barrier.
    Hamester F; Stürken C; Saygi C; Qi M; Legler K; Gorzelanny C; Robador JR; Schmalfeldt B; Laakmann E; Müller V; Witzel I; Oliveira-Ferrer L
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor intrinsic subtype is reflected in cancer-adjacent tissue.
    Casbas-Hernandez P; Sun X; Roman-Perez E; D'Arcy M; Sandhu R; Hishida A; McNaughton KK; Yang XR; Makowski L; Sherman ME; Figueroa JD; Troester MA
    Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):406-14. PubMed ID: 25465802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.